BioNTech SE (BNTX) Gross Profit (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Gross Profit data on file, last reported at $668.3 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit fell 33.93% year-over-year to $668.3 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 billion (up 7.83% YoY), and the FY2025 full-year result was $2.5 billion, up 6.6% from the prior year.
• Gross Profit declined to $668.3 million in Q4 2025, from $1.6 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $6.3 billion in Q4 2021 to a low of $5.2 million in Q2 2023.
• A 5-year average of $2.2 billion and a median of $1.3 billion in 2023 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 13300.85% in 2021, while the deepest fall reached 100.0% in 2021.
• Tracing BNTX's Gross Profit over 5 years: stood at $6.3 billion in 2021, then sank by 33.99% to $4.2 billion in 2022, then sank by 66.52% to $1.4 billion in 2023, then decreased by 27.68% to $1.0 billion in 2024, then slumped by 33.93% to $668.3 million in 2025.
• Business Quant data shows BNTX's Gross Profit at $668.3 million in Q4 2025, $1.6 billion in Q3 2025, and $208.7 million in Q2 2025.